Cargando…
First report of post-transplant autoimmune hepatitis recurrence following SARS-CoV-2 mRNA vaccination
Whilst vaccination for the SARS-CoV-2 virus has been successful in reducing the severity and burden of the COVID-19 pandemic, there have been recent reports of mRNA vaccines triggering autoimmune hepatitis in the native liver. There have been no descriptions thus far of recurrent ‘autoimmune hepatit...
Autores principales: | Mahalingham, Aarani, Duckworth, Adam, Griffiths, William J.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977213/ https://www.ncbi.nlm.nih.gov/pubmed/35390478 http://dx.doi.org/10.1016/j.trim.2022.101600 |
Ejemplares similares
-
Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients
por: Crane, Clarkson, et al.
Publicado: (2021) -
Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis
por: Harputluoglu, Murat, et al.
Publicado: (2022) -
Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020) -
Anti-SARS-CoV-2 vaccine in liver transplantation
por: Kotsiliti, Eleni
Publicado: (2022) -
Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients
por: Hoffman, T.W., et al.
Publicado: (2022)